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ABSTRACT Due to their ability to integrate into the host cell’s genome, retroviruses represent an optimal basis for the creation of gene therapy vectors. the integra-
tion reaction is carried out by a viral enzyme integrase: thus, a detailed research of this enzyme is required. In this work, the catalytic properties of human foamy 
virus integrase were studied. this virus belongs to the retroviridae family. the dissociation constant was determined, together with the kinetics of integrase 
catalytic activity. the data obtained were compared to those for the human immunodeficiency virus integrase and a considerable similarity in the activity of the 
two enzymes was observed.  
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D
ue to their ability to integrate into the genomes of 
non-dividing cells, retroviruses are widely used 
as a base for gene therapy vectors construction. A 
number of papers [1-6] report on systems employing human 
immunodeficiency virus type 1 integrase (HIV-1 In) as a 
basis for the creation of constructs enabling integration of a 
certain vector into a given DnA sequence. However, direct-
ed integration vectors on the basis of HIV carry a potential 
danger to human health because of their high pathogenic-
ity. In this regard, human foamy virus (HFV), which infects 
human cells efficiently, but is not pathogenic [7], seems at-
tractive. HFV belongs to the Spumaviridae genus of the 
retrovirus family and carries an enzyme, integrase (HFV 
In), which accomplishes the integration of the viral genome 
into the host cell’s genome. At present, the HFV In cata-
lytic properties are relatively little-studied. In this paper, 
an attempt has been made to explore the In HFV catalytic 
properties and compare them with those of HIV-1 In, so as 
to evaluate the potential for using HFV integrase for site-
directed integration.
One of the factors hampering the study of the catalytic 
properties of retroviral integrases is their low activity: to 
accomplish 3’-processing, a very large excess of the en-
zyme over DnA is required (usually > 30:1). therefore, in 
our study of the HFV In properties we first explored the 
dependence of the 3’-processing efficiency on the enzyme 
concentration in the reaction mixture. to this end, synthetic 
DnA duplexes imitating the terminal sequence of the u5 
domain of the viral DnA’s long terminal repeat were em-
ployed. Incubation of In with such DnA-substrate resulted 
in dinucleotide removal from the 3’-end of the processed 
strand (u5B-strand). For both Ins, maximum reaction ef-
ficiency was achieved at an enzyme concentration of 100 
nM (Figure 1). HIV In’s low enzymatic activity is accounted 
for by the single-turnover mechanism of the catalytic proc-
ess, the causes for which include the formation of a strong 
complex between the enzyme and the DnA sequence [8]. 
therefore, in the next step of our study of the HFV In prop-
erties we explored the DnA-binding stage of the integration 
process.
In order to determine the dissociation constant of the 
HFV In-DnA complex, we examined 2 or 10 nM DnA sub-
strates binding at different enzyme concentrations (Figure 
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Figure 1. The influence of the HIV-1 (white spots) and HFV (black spots) 
integrase concentrations on the outcome of the 3’-processing reaction. 
The integrase solution (5nM - 5µM) was incubated with a 4 nM DNA 
substrate for 1h at 37 °CreSeArcH ArtIcLeS
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2A). Application of the approach based on the simple ligand-
receptor interaction theory to the system under study al-
lowed employing equation (1)
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to calculate the Kd value, which appeared to be 15-20 nM. 
this value indicates that the DnA forms a rather stronger 
complex with HFV In than with HIV In (40 nM [8]).
We also studied the DnA-binding kinetics of both en-
zymes by the fluorescence polarization method. the experi-
ment was performed at 25°c, since it is known that under 
such conditions retroviral Ins are capable of associating with 
their substrates without executing the substrates processing. 
When the In solution was added to a fluorescently labeled 
DnA-duplex, an abrupt increase in the fluorescence signal’s 
anisotropy, conditioned by a slower complex rotation, was 
observed (Figure 2B). the DnA-HIV In complex formation 
is accomplished in 3-4 minutes, which is approximately five 
times longer than the time required for the DnA association 
with HFV In [8]. this fact is also indicative of greater favo-
rability of HFV In binding to the DnA.
the results obtained accord well with the data on the 
time dependence of accumulation of the DnA-substrate’s 
catalytic conversion products. Figure 3 presents the curves 
corresponding to accumulation of the products of the 
3’-processing and strand-transfer reactions catalyzed by 
the two Ins.
It can be seen that the lag-phase, preceding the lin-
ear growth phase of product accumulation, character-
istic of HIV In action, is entirely absent in the case of 
HFV In. Instead, the process passes straight into the 
linear  growth  phase.  the  calculated  stationary  rates 
of product formation at this stage have similar val-
ues for both integrases (Vlinear (HIV) = 0.011 nmole/min, 
Vlinear (HFV) = 0.014 nmole/min) and are remarkably low, 
which is not typical for a multiple-turnover mode of the en-
zyme action at the concentrations concerned. It has been 
shown that the reason for such behavior of HIV Ins isolated 
in the presence of zinc ions and in the absence of detergents 
according to the procedure in [9] is their low natural cata-
lytic activity rather than low active protein form content 
in the preparations used. this leads to the inapplicability 
of the classical Michaelis-Menten formalism to the descrip-
tion of HIV In’s catalytic action. Instead, one has to employ 
kinetic equations which assume that the reactions catalyzed 
by the In proceed under so-called “single-turnover” condi-
tions, implicating a large excess of enzyme over the sub-
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Figure 2. The binding of DNA with HIV and HFV Ins. (a). The isotherm of 
IN HFV binding a 2nM U5-HFV substrate. The incubation was carried out 
for 20 min at 25 °C in buffer solution containing 20 mM Tris (pH 7.2), 20 
mM NaCl, 1 mM DTT, and a 5 mM MgCl2. The DNA/protein complexes 
were analyzed by gel retardation assay. (b). The fluorescence polariza-
tion assay was applied for constructing the kinetics of the binding of a 4 
nM DNA substrate by 100 nM HIV (white spots) and HFV (black spots) 
integrases at 25 °C
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Figure 3. The kinetics of the 3’-processing reaction. The product ac-
cumulation curve of a 4 nM U5 substrate 3’-processing reaction while 
incubated with a 100 nM HIV (white spots) and HFV (black spots) 
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strate [8]. the same assumption was made in case of HFV 
In. the value of the catalytic constant analogue determined 
using the “single-turnover” approach appeared to be virtu-
ally the same for both enzymes (kcat
’ = 0.004±0.001 min-1), 
which also denotes similar properties of both integrases. 
Moreover, it should be noted that the value of the Michaelis 
constant analogue computed from kinetic data for HIV In 
(Km = 30±5 nМ) coincides well with the value of the HIV 
In-DnA complex dissociation constant (Kd = 40 nМ). At the 
same time, for HFV In such correlation is not observed. the 
calculated Km’ = 60±10 nМ correlates very poorly with the 
determined Kd value (15-20 nM). Further we are planning to 
study the reasons for such a discrepancy.  
In conclusion, our results demonstrate that HIV In is sim-
ilar to HIV-1 In in its kinetic characteristics. In the nearest 
future, we plan to use this enzyme for creating a directed 
DnA integration system.
ExPERIMENTAL SECTION
Oligonucleotides 
u5B-HIV (5’-GtGtGGAAAAtctctAGcAGt-3’),
u5A-HIV (5’-ActGctAGAGAttttcAcAc-3’),
u5B-HFV (5’-AtAcAAAAttccAt  GAcAAt-3’),
u5A-HFV (5’-AttGtcAtGGAAttttGtAt-3’)
were synthesized by the amidophosphite method on an 
automatic DnA synthesizer ABI 394 (Applied Biosystems) 
according to the standard procedure using commercial re-
agents (Glen research) and purified by electrophoresis in 
20% polyacrylamide gel containing 7M urea.
Recombinant HIV-1 integrase was expressed in es-
cherichia coli, isolated and purified without detergent as 
previously described [9]. HFV integrase was a kind gift of 
Dr. Mouscadet J-F. (normal Superior School of cachan, 
France).
3’-Processing was performed by incubating the corre-
sponding 4 nM DnA-substrate, containing 5’-[P32]-labeled 
processed strand u5B and HFV In or HIV In in 20 μL buffer 
(20 mM Hepes (pH 7.2), 1 mM Dtt and 7.5 mM Mgcl2), at 
37°c. the reaction was arrested by adding 80 μL of solution 
containing 10 mM tris-Hcl (pH 7.5), 0.3 M sodium acetate, 
1 mM eDtA, and 0.125 μg /ml glycogen; the integrase was 
extracted with phenol, the reaction products were precipi-
tated with ethanol and resuspended in 80% formamide-wa-
ter solution. the products were separated by electrophoresis 
in 20% polyacrylamide gel under denaturating conditions 
(7M urea) with subsequent gel analysis on a Phosphorim-
ager. the 3’-processing completion was determined by the 
appearance of a band corresponding to a 2-nucleotide trun-
cated processed strand of the duplex on a radiograph.
Gel-retardation method. [P32]-labeled DnA-substrate (2 
or 10 nM) was incubated with HFV In of different concen-
trations (0-300 nM) in a buffer containing 20 mM HePeS, 
pH 7.2, 1 mM Dtt, 7.5 mM Mgcl2, and 5% glycerin at 25°c 
for 20 min. Afterwards, the mixture was analyzed by elec-
trophoresis in 8% polyacrylamide gel in a buffer containing 
20 mM tris-cH3cOOH, pH 7.5, and 7.5 mM Mgcl2 at 4-8°c. 
Gel was analyzed using a StOrM 840tM Phosphorimager 
(Molecular Dynamics). the effective dissociation constant 
was computed using equation (1).
Fluorescence polarization method. DnA-substrate (4 nM) 
containing a fluorescein residue in the 5’-processed strand 
u5B, was incubated with 100 nM HFV In or HIV In in 200 
μL buffer containing 20 mM HePeS, pH 7.2, 1 mM dithioth-
reitol, and 7.5 mM Mgcl2 at 37°c. the fluorescence anisotropy 
alteration during the incubation was registered using a cary 
eclipse spectrophotometer (Varian).
computation of the Michaelis constant and the catalytic 
constant analogues was done in a single-turnover mode using 
equation (2) according to the previously reported data [8]:
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